Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Cogent Biosciences (COGT) Revenue (2017 - 2020)

Cogent Biosciences (COGT) has 3 years of Revenue data on record, last reported at $312000.0 in Q3 2020.

  • For Q3 2020, Revenue fell 69.41% year-over-year to $312000.0; the TTM value through Jun 2021 reached $312000.0, down 98.69%, while the annual FY2025 figure was -$3.1 million, N/A changed from the prior year.
  • Revenue reached $312000.0 in Q3 2020 per COGT's latest filing, down from $528000.0 in the prior quarter.
  • Across five years, Revenue topped out at $15.3 million in Q4 2019 and bottomed at $312000.0 in Q3 2020.
  • Average Revenue over 3 years is $3.6 million, with a median of $2.2 million recorded in 2018.
  • Peak YoY movement for Revenue: skyrocketed 301.79% in 2019, then crashed 83.17% in 2020.
  • A 3-year view of Revenue shows it stood at $3.8 million in 2018, then surged by 301.79% to $15.3 million in 2019, then plummeted by 97.96% to $312000.0 in 2020.
  • Per Business Quant database, its latest 3 readings for Revenue were $312000.0 in Q3 2020, $528000.0 in Q2 2020, and $7.0 million in Q1 2020.